New Treatments for Back Pain Without Surgery: Clinically Proven Options That Work

Back pain is one of the most common and costly health conditions worldwide, affecting over 600 million people and accounting for billions in lost productivity and healthcare spending. In San Diego and across the U.S., patients are increasingly seeking non-surgical solutions—especially those that are effective, evidence-based, and minimally invasive. Fortunately, recent clinical research has validated several promising therapies that offer real relief without the risks of surgery.

Here’s a look at the most compelling non-surgical treatments for chronic back pain, including Class IV laser therapy, regenerative stem cell injections, cannabis-based medications, and disc allograft procedures—all backed by peer-reviewed studies.

1. Class IV Laser Therapy: Deep Relief Without Drugs or Surgery

Class IV laser therapy uses high-powered infrared light to penetrate deep into muscle and joint tissue, stimulating cellular repair and reducing inflammation. Unlike cold lasers, which only reach superficial layers, Class IV lasers deliver up to 72 watts of energy and reach up to 7 inches deep.

Clinical evidence supports its effectiveness:

• A 2019 study in the Open Access Journal of Medical Sciences found that patients with chronic low back pain treated with high-intensity laser therapy experienced significant reductions in pain and disability, with improvements sustained for three months (Pankonin, 2024).
• A 2023 meta-analysis in the Journal of Clinical Medicine reviewed 44 randomized trials and concluded that Class IV laser therapy improves pain, range of motion, and quality of life in musculoskeletal disorders, including chronic back pain.

At Healios Laser Therapy in San Diego, patients often report noticeable relief within 1–4 sessions, with no downtime or side effects. It’s a frontline option for disc pain, facet joint irritation, muscle strain, and spinal stenosis.

2. Stem Cell Therapy for Degenerative Disc Disease

Regenerative medicine is rapidly advancing, and stem cell therapy is at the forefront for treating degenerative disc disease (DDD)—a leading cause of chronic back pain. The FDA recently approved a Phase 3 trial of DiscGenics’ injectable disc cell therapy (IDCT), which uses discogenic cells derived from donated human disc tissue.

Key findings from earlier trials:

• Patients receiving high-dose IDCT reported a 63% reduction in pain intensity and sustained improvements in disability and quality of life for up to two years.
• MRI imaging confirmed disc regeneration and structural improvements (Pain News Network, 2024).

This therapy offers a single-injection alternative to spinal fusion or disc replacement, with promising durability and minimal invasiveness.

3. Cannabis-Based Medication: VER-01 Extract

A groundbreaking Phase 3 trial published in Nature Medicine tested VER-01, a full-spectrum cannabis extract, in over 800 patients with chronic low back pain. The results were striking:

• Patients taking VER-01 reported a 2.9-point reduction in pain on a 10-point scale after six months, compared to 0.6 for placebo.
• Improvements were also seen in sleep quality, physical function, and overall quality of life.
• No serious side effects or addictive properties were observed (Karst et al., 2025).

Unlike generic CBD or THC products, VER-01 is a standardized extract designed for medical use. It may soon be available as a prescription option for chronic pain management.

4. Nucleus Pulposus Allograft (VIA Disc NP)

VIVEX Biologics has developed VIA Disc NP, a minimally invasive procedure that injects donor nucleus pulposus tissue into degenerated spinal discs. This approach aims to restore disc hydration and function, reducing pain at its source.

Clinical trial highlights:

• Participants reported a drop in pain scores from 7.1 to 3.8 over 12 months.
• Oswestry Disability Index scores improved from 53 to 24, indicating restored function.
• 60% of patients reported pain scores of 3 or less at one year (McClure, 2025).

The procedure is done under sedation with local anesthesia, and patients typically resume normal activities the next day. It’s a viable option for discogenic pain that hasn’t responded to conservative care.

5. REXLEMESTROCEL-L: Regenerative Cell Therapy for Disc Repair

Mesoblast’s REXLEMESTROCEL-L combines mesenchymal precursor cells with hyaluronic acid, delivered via a single injection into the spinal disc. This therapy targets inflammation and promotes tissue repair.

The ongoing Phase 3 trial aims to:

• Evaluate long-term pain relief and disc regeneration in patients with DDD.
• Offer a disease-modifying alternative to surgery or chronic medication use.
• Provide durable results through biologic repair mechanisms (Desert Spine & Sports Physicians, 2025).

If successful, this therapy could become the first FDA-approved regenerative treatment for chronic low back pain.

Final Thoughts: A New Era of Back Pain Relief

Surgery is no longer the only path to recovery. With Class IV laser therapy, stem cell injections, cannabis-based medications, disc allografts, and regenerative biologics, patients now have access to a range of clinically validated treatments that restore function and reduce pain—without the risks and recovery time of invasive procedures.

For San Diego residents, Healios Laser Therapy offers one of the most accessible and effective options. Their Class IV laser protocols are tailored to each patient’s condition and goals, delivering fast results with zero downtime.

Learn more about how a laser therapy treatment can help back pain.

References

• Karst, M., et al. (2025). Full-spectrum extract from Cannabis sativa DKJ127 for chronic low back pain: A phase 3 randomized placebo-controlled trial. Nature Medicine. https://doi.org/10.1038/s41591-025-03977-0
• Pankonin, K. J. (2024). Class IV Laser Therapy: Research, Conditions & Outcomes. Open Access Journal of Medical Sciences. https://cdn.ymaws.com/wichiro.org/resource/resmgr/class-notes/2024/sp24_class_notes/class_iv_laser_therapy_slide.pdf
• Pain News Network. (2024, July 25). FDA Approves Stem Cell Study for Degenerative Disc Disease. https://www.painnewsnetwork.org/stories/2024/7/25/fda-approves-study-of-stem-cell-injection-for-degenerative-disc-disease
• McClure, P. (2025, May 6). New treatment for spinal disc pain shows promising clinical results. New Atlas. https://newatlas.com/chronic-pain/nucleus-pulposus-allograft-back-pain-clinical-trial/
• Desert Spine & Sports Physicians. (2025, September 9). Phase III Trial of REXLEMESTROCEL-L for Chronic Low Back Pain. https://www.desertspineandsports.com/dssp-phase-iii-trial-rexlemestrocel-l-chronic-low-back-pain/